ABVX – Abivax ADR

ABVX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.18

Margin Of Safety %

Put/Call OI Ratio

0.36

EPS Next Q Diff

0.82

EPS Last/This Y

1.17

EPS This/Next Y

0.34

Price

87.63

Target Price

157.26

Analyst Recom

1.28

Performance Q

-27.46

Upside

-190.5%

Beta

1.49

Ticker: ABVX

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	ABVX	87.92	0.41	0.57	232608
2026-10-15	ABVX	92.51	0.41	1.16	236622
2026-10-16	ABVX	88.2	0.40	2.60	241357
2026-10-19	ABVX	87.52	0.40	0.22	201489
2026-10-20	ABVX	92.56	0.40	0.18	205145
2026-10-21	ABVX	93.49	0.39	0.33	209304
2026-10-22	ABVX	90.31	0.39	0.39	211225
2026-10-23	ABVX	88.07	0.39	1.12	212491
2026-10-26	ABVX	86.5	0.36	0.24	201375
2026-10-27	ABVX	87.06	0.35	0.19	203269
2026-10-28	ABVX	89.84	0.35	0.19	204720
2026-10-29	ABVX	89.14	0.35	0.48	206501
2026-10-30	ABVX	86.68	0.35	0.64	208103
2026-11-02	ABVX	84.82	0.35	0.20	202745
2026-11-03	ABVX	88.7	0.35	0.32	203902
2026-11-04	ABVX	89.41	0.35	1.48	205828
2026-11-05	ABVX	84.11	0.36	0.16	209328
2026-11-06	ABVX	85.71	0.36	0.34	211511
2026-11-09	ABVX	87.09	0.36	0.15	206532
2026-11-10	ABVX	89.94	0.36	0.17	207255
2026-11-11	ABVX	91.31	0.35	0.60	210337
2026-11-12	ABVX	90.17	0.36	0.44	212730
2026-11-13	ABVX	87.63	0.36	0.30	214421
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	ABVX	88.01	63.5	-	-4.24
2026-10-15	ABVX	92.36	65.2	-	-4.19
2026-10-16	ABVX	88.10	65.2	-	-4.19
2026-10-19	ABVX	87.50	65.2	-	-4.19
2026-10-20	ABVX	87.50	65.2	-	-4.19
2026-10-21	ABVX	92.44	65.2	-	-4.19
2026-10-22	ABVX	90.30	65.2	-	-4.18
2026-10-23	ABVX	88.00	65.2	-	-4.18
2026-10-26	ABVX	86.49	65.3	-	-4.17
2026-10-27	ABVX	87.03	65.3	-	-4.17
2026-10-28	ABVX	89.82	65.3	-	-4.17
2026-10-29	ABVX	89.08	65.3	-	-4.17
2026-10-30	ABVX	86.68	65.3	-	-4.17
2026-11-02	ABVX	84.85	65.3	-	-4.17
2026-11-03	ABVX	88.66	65.3	-	-4.17
2026-11-04	ABVX	89.51	65.3	-	-4.17
2026-11-05	ABVX	84.18	65.3	-	-4.17
2026-11-06	ABVX	85.68	65.3	-	-4.17
2026-11-09	ABVX	87.01	65.3	-	-4.17
2026-11-10	ABVX	90.05	65.3	-	-4.17
2026-11-11	ABVX	91.29	65.3	-	-4.17
2026-11-12	ABVX	90.28	65.3	-	-4.17
2026-11-13	ABVX	87.63	65.3	-	-4.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	ABVX	0.00	13.76	9.81
2026-10-15	ABVX	0.00	13.76	9.81
2026-10-16	ABVX	0.00	13.76	9.81
2026-10-19	ABVX	0.00	10.89	9.81
2026-10-20	ABVX	0.00	10.89	9.81
2026-10-21	ABVX	0.00	10.89	9.81
2026-10-22	ABVX	0.00	10.89	9.81
2026-10-23	ABVX	0.00	10.89	9.81
2026-10-26	ABVX	0.00	10.62	9.81
2026-10-27	ABVX	0.00	10.62	9.15
2026-10-28	ABVX	0.00	10.62	9.15
2026-10-29	ABVX	0.00	10.62	9.15
2026-10-30	ABVX	0.00	10.62	9.15
2026-11-02	ABVX	0.00	10.62	9.15
2026-11-03	ABVX	0.00	10.62	9.15
2026-11-05	ABVX	0.00	10.62	9.15
2026-11-06	ABVX	0.00	10.62	9.15
2026-11-09	ABVX	0.00	10.49	9.15
2026-11-10	ABVX	0.00	10.49	9.15
2026-11-11	ABVX	0.00	10.49	5.18
2026-11-12	ABVX	0.00	10.49	5.18
2026-11-13	ABVX	0.00	10.49	5.18
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-1.71

Avg. EPS Est. Current Quarter

-0.86

Avg. EPS Est. Next Quarter

-0.89

Insider Transactions

Institutional Transactions

10.49

Beta

1.49

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

41.1

Max Drawdown 5-Year %

Target Price

157.26

P/E

Forward P/E

PEG

P/S

P/B

16.69

P/Free Cash Flow

EPS

-6.1

Average EPS Est. Cur. Y

-4.17

EPS Next Y. (Est.)

-3.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.54

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.59

EBIT Estimation

◆ ABVX Healthcare

$87.58

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

8/10

RSI

45.5

Range 1M

35%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

9/30

Estimates

0/20

Inst/Vol

5/15

Options

8/10

EPS Yr

24.8%

EPS NY

5.3%

52W%

23.1%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +79.6% upside

Quality

2/30

Valuation

12/30

Growth

7/25

Stability

7/10

LT Trend

4/5

Upside

+79.6%

Quality

ABVX — P/E HistoricalBiotechnology

Abivax SA

Sector: Healthcare

Industry: Biotechnology

Employees: 98

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

ABVX

Latest News

—

Caricamento notizie per ABVX…

stock quote shares ABVX – Abivax ADR Stock Price stock today

news today ABVX – Abivax ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch ABVX – Abivax ADR yahoo finance google finance

stock history ABVX – Abivax ADR invest stock market

stock prices ABVX premarket after hours

ticker ABVX fair value insiders trading

SNY – Sanofi

SNY — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.52

Margin Of Safety %

Put/Call OI Ratio

0.75

EPS Next Q Diff

EPS Last/This Y

1.52

EPS This/Next Y

0.37

Price

48.36

Target Price

52.56

Analyst Recom

1.9

Performance Q

8.92

Upside

-47.9%

Beta

0.26

Ticker: SNY

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	SNY	39.76	0.73	0.31	93976
2026-10-15	SNY	40.29	0.73	4.81	94057
2026-10-16	SNY	40.59	0.75	0.20	95155
2026-10-19	SNY	39.57	0.79	0.19	90530
2026-10-20	SNY	41.4	0.78	0.57	92592
2026-10-21	SNY	40.97	0.78	2.28	93108
2026-10-22	SNY	41.95	0.78	0.24	93302
2026-10-23	SNY	41.58	0.76	0.26	94600
2026-10-26	SNY	41.79	0.76	0.21	94728
2026-10-27	SNY	41.88	0.76	0.58	94788
2026-10-28	SNY	42.25	0.77	0.65	95057
2026-10-29	SNY	43.13	0.77	0.49	95167
2026-10-30	SNY	44.35	0.77	0.71	95628
2026-11-02	SNY	45.54	0.78	0.10	96139
2026-11-03	SNY	45.33	0.74	0.46	98613
2026-11-04	SNY	47.45	0.74	0.23	98810
2026-11-05	SNY	46.91	0.74	6.89	99382
2026-11-06	SNY	47.01	0.78	17.50	102022
2026-11-09	SNY	48.12	0.75	0.45	100555
2026-11-10	SNY	48.23	0.72	1.67	103507
2026-11-11	SNY	48.42	0.72	1.10	104485
2026-11-12	SNY	48.46	0.72	5.29	105300
2026-11-13	SNY	48.37	0.75	0.45	107178
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	SNY	39.76	-10.7	638.2	4.93
2026-10-15	SNY	40.28	-10.7	560.7	4.93
2026-10-16	SNY	40.61	-10.7	570.6	4.93
2026-10-19	SNY	39.55	-10.7	351.6	4.93
2026-10-20	SNY	39.55	-10.7	351.6	4.93
2026-10-21	SNY	41.40	-10.7	813.9	4.93
2026-10-22	SNY	41.96	-10.7	672.8	4.93
2026-10-23	SNY	41.59	-10.7	471.4	4.93
2026-10-26	SNY	41.78	-10.7	590.0	4.93
2026-10-27	SNY	41.89	-10.7	593.3	4.90
2026-10-28	SNY	42.24	-10.7	654.0	4.90
2026-10-29	SNY	43.12	-10.7	690.3	4.90
2026-10-30	SNY	44.37	-10.7	687.0	4.90
2026-11-02	SNY	45.54	22.7	-63.5	4.90
2026-11-04	SNY	47.44	-4.8	11.3	5.03
2026-11-05	SNY	46.90	-4.8	1978.4	5.03
2026-11-06	SNY	47.01	-4.8	2158.1	5.03
2026-11-09	SNY	48.12	-4.8	2396.0	5.03
2026-11-10	SNY	48.22	-4.8	2141.6	5.03
2026-11-11	SNY	48.43	-4.8	2146.1	5.06
2026-11-12	SNY	48.46	-4.8	2227.3	5.06
2026-11-13	SNY	48.36	-4.8	2174.8	5.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	SNY	0	-0.37	0.45
2026-10-15	SNY	0	-0.37	0.45
2026-10-16	SNY	0	-0.37	0.45
2026-10-19	SNY	0	-0.55	0.45
2026-10-20	SNY	0	-0.55	0.45
2026-10-21	SNY	0	-0.55	0.45
2026-10-22	SNY	0	-0.55	0.45
2026-10-23	SNY	0	-0.55	0.45
2026-10-26	SNY	0	-0.56	0.45
2026-10-27	SNY	0	-0.56	0.49
2026-10-28	SNY	0	-0.56	0.49
2026-10-29	SNY	0	-0.56	0.49
2026-10-30	SNY	0	-0.56	0.49
2026-11-02	SNY	0	-0.82	0.49
2026-11-03	SNY	0	-0.82	0.49
2026-11-05	SNY	0	-0.82	0.49
2026-11-06	SNY	0	-0.82	0.49
2026-11-09	SNY	0	-0.68	0.49
2026-11-10	SNY	0	-0.68	0.49
2026-11-11	SNY	0	-0.68	0.52
2026-11-12	SNY	0	-0.68	0.52
2026-11-13	SNY	0	-0.68	0.52
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

2.04

Avg. EPS Est. Current Quarter

0.87

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.68

Beta

0.26

Average Sales Estimate Current Quarter

12910

Average Sales Estimate Next Quarter

Fair Value

55.58

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

19.5

Max Drawdown 5-Year %

-33.5

Target Price

52.56

P/E

24.91

Forward P/E

9.15

PEG

1.26

P/S

2.16

P/B

1.48

P/Free Cash Flow

9.56

EPS

1.94

Average EPS Est. Cur. Y

5.06

EPS Next Y. (Est.)

5.43

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.78

Relative Volume

0.5

Return on Equity vs Sector %

-20.7

Return on Equity vs Industry %

-29

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.13

EBIT Estimation

2174.8

◆ SNY Healthcare

$48.37

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

4/20

Pullback

8/25

Volume

11/15

Valuation

12/20

TP/AR

1/10

Options

4/10

RSI

76.2

Range 1M

94.4%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

14/25

Growth

13/30

Estimates

6/20

Inst/Vol

1/15

Options

8/10

EPS Yr

6.3%

EPS NY

6.5%

52W%

68.8%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟡 HOLD +29.2% upside

Quality

14/30

Valuation

12/30

Growth

10/25

Stability

2/10

LT Trend

1/5

Upside

+29.2%

Quality

MoS

15%

SNY — P/E HistoricalDrug Manufacturers - General

Sanofi

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 74846

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions in Finland and Germany. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection; hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines; and Fluzone, a flu vaccine. It has a collaboration and license agreement with Exscientia to develop small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab; and antibody collaboration with Regeneron Pharmaceuticals, Inc. to develop antibodies, such as Dupixent (dupilumab) as treatment for diseases driven by type 2 inflammation. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

SNY

Latest News

—

Caricamento notizie per SNY…

stock quote shares SNY – Sanofi Stock Price stock today

news today SNY – Sanofi stock forecast ,stock prediction 2023 2024 2025

marketwatch SNY – Sanofi yahoo finance google finance

stock history SNY – Sanofi invest stock market

stock prices SNY premarket after hours

ticker SNY fair value insiders trading

TTE – Total Energies SE

TTE — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

0.2

Margin Of Safety %

-11

Put/Call OI Ratio

0.89

EPS Next Q Diff

EPS Last/This Y

7.05

EPS This/Next Y

-0.75

Price

90.78

Target Price

103.25

Analyst Recom

1.82

Performance Q

2.43

Upside

46.5%

Beta

0.19

Ticker: TTE

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	TTE	89.68	0.90	0.50	60100
2026-10-15	TTE	88.5	0.90	0.26	60110
2026-10-16	TTE	91.37	0.90	0.14	60029
2026-10-19	TTE	89.94	1.00	0.07	53116
2026-10-20	TTE	90.1	0.91	0.51	56314
2026-10-21	TTE	90.32	0.91	3.41	56455
2026-10-22	TTE	90.94	0.91	0.40	56653
2026-10-23	TTE	92.79	0.91	0.31	56785
2026-10-26	TTE	93.76	0.90	0.32	57471
2026-10-27	TTE	92.41	0.90	0.34	57646
2026-10-28	TTE	92.88	0.90	0.56	57684
2026-10-29	TTE	94.03	0.90	0.42	57807
2026-10-30	TTE	95.39	0.90	0.41	57986
2026-11-02	TTE	92.79	0.90	0.64	58214
2026-11-03	TTE	92.72	0.90	0.81	58309
2026-11-04	TTE	90.43	0.90	0.54	58400
2026-11-05	TTE	88.79	0.90	0.05	58622
2026-11-06	TTE	87.86	0.88	2.08	59139
2026-11-09	TTE	88.01	0.89	0.39	59365
2026-11-10	TTE	87.87	0.89	0.51	59540
2026-11-11	TTE	87.92	0.89	0.81	59520
2026-11-12	TTE	89.47	0.89	1.23	59666
2026-11-13	TTE	90.75	0.89	1.11	59852
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	TTE	89.66	-	1597.5	11.18
2026-10-15	TTE	88.48	-	1218.7	11.65
2026-10-16	TTE	91.28	-	1829.4	11.65
2026-10-19	TTE	89.98	-	910.9	11.87
2026-10-20	TTE	89.98	-	910.9	11.87
2026-10-21	TTE	90.08	-	1263.1	12.23
2026-10-22	TTE	90.96	-	1595.0	12.33
2026-10-23	TTE	92.81	-	1981.8	12.33
2026-10-26	TTE	93.76	-	1770.0	12.36
2026-10-27	TTE	92.32	-	1369.8	12.36
2026-10-28	TTE	92.94	-	1432.9	12.36
2026-10-29	TTE	94.03	-	2032.2	12.36
2026-10-30	TTE	95.33	-	-5329.5	12.36
2026-11-02	TTE	92.79	-	-6441.1	12.36
2026-11-04	TTE	90.42	98.8	-3311.9	12.51
2026-11-05	TTE	88.73	98.8	-3435.9	12.68
2026-11-06	TTE	87.84	119.2	-3102.4	12.68
2026-11-09	TTE	88.04	120.7	-2607.1	12.73
2026-11-10	TTE	87.89	125.2	-2742.7	12.89
2026-11-11	TTE	87.94	125.2	-2949.7	12.89
2026-11-12	TTE	89.52	125.2	-2145.9	12.89
2026-11-13	TTE	90.78	125.2	-2440.1	12.89
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	TTE	0.00	-0.02	0.23
2026-10-15	TTE	0.00	-0.02	0.23
2026-10-16	TTE	0.00	-0.02	0.23
2026-10-19	TTE	0.00	0.10	0.23
2026-10-20	TTE	0.00	0.10	0.23
2026-10-21	TTE	0.00	0.10	0.23
2026-10-22	TTE	0.00	0.10	0.23
2026-10-23	TTE	0.00	0.10	0.23
2026-10-26	TTE	0.00	-0.10	0.23
2026-10-27	TTE	0.00	-0.10	0.23
2026-10-28	TTE	0.00	-0.10	0.23
2026-10-29	TTE	0.00	-0.10	0.23
2026-10-30	TTE	0.00	-0.10	0.23
2026-11-02	TTE	0.00	-1.14	0.23
2026-11-03	TTE	0.00	-1.14	0.23
2026-11-05	TTE	0.00	-1.14	0.23
2026-11-06	TTE	0.00	-1.14	0.23
2026-11-09	TTE	0.00	-1.04	0.23
2026-11-10	TTE	0.00	-1.04	0.23
2026-11-11	TTE	0.00	-1.04	0.20
2026-11-12	TTE	0.00	-1.04	0.20
2026-11-13	TTE	0.00	-1.04	0.20
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

3.9

Avg. EPS Est. Next Quarter

3.45

Insider Transactions

Institutional Transactions

-1.04

Beta

0.19

Average Sales Estimate Current Quarter

62714

Average Sales Estimate Next Quarter

68180

Fair Value

80.51

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.2

Max Drawdown 5-Year %

-26.3

Target Price

103.25

P/E

Forward P/E

7.77

PEG

0.64

P/S

0.93

P/B

1.51

P/Free Cash Flow

8.86

EPS

10.09

Average EPS Est. Cur. Y

12.89

EPS Next Y. (Est.)

12.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.46

Relative Volume

0.47

Return on Equity vs Sector %

Return on Equity vs Industry %

1.7

EPS 1 7Days Diff

0.4

EPS 1 30Days Diff

1.58

EBIT Estimation

-2440.1

◆ TTE Energy

$90.78

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

10/20

Pullback

15/25

Volume

11/15

Valuation

8/20

TP/AR

1/10

Options

2/10

RSI

Range 1M

44.3%

Sup Dist

2.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

19/30

Estimates

4/20

Inst/Vol

2/15

Options

4/10

EPS Yr

86.4%

EPS NY

-9.1%

52W%

84.4%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +36.3% upside

Quality

16/30

Valuation

13/30

Growth

12/25

Stability

3/10

LT Trend

3/5

Upside

+36.3%

Quality

MoS

-11%

TTE — P/E HistoricalOil & Gas Integrated

TotalEnergies SE

Sector: Energy

Industry: Oil & Gas Integrated

Employees: 94847

TotalEnergies SE, an integrated energy company, produces and markets oil and biofuels, natural gas, biogas and low-carbon hydrogen, renewables, and electricity in France, the United States, Europe, Africa, and internationally. It operates through Exploration & Production, Integrated LNG, Integrated Power, Refining & Chemicals, and Marketing & Services segments. The Exploration & Production segment engages in the activities of exploration and production of oil and natural gas, as well as carbon storage. The Integrated LNG segment is involved in the upstream and midstream LNG activities, as well as biogas and synthetic methane activities, as well as gas trading. The Integrated Power segment engages in the generation, storage, electricity trading, and B2B-B2C distribution of gas and electricity. The Refining & Chemicals segment is involved in the industrial hub activities comprising the activities of refining, petrochemicals and specialty chemicals. This segment also includes the activities of oil supply, trading and marine shipping, as well as hydrogen activities. The Marketing & Services segment engages in the marketing activities in the field of petroleum products, as well as corresponding supply and logistics activities. The company was formerly known as TOTAL SE and changed its name to TotalEnergies SE in June 2021. TotalEnergies SE was incorporated in 1924 and is headquartered in Courbevoie, France.

TTE

Latest News

—

Caricamento notizie per TTE…

stock quote shares TTE – Total Energies SE Stock Price stock today

news today TTE – Total Energies SE stock forecast ,stock prediction 2023 2024 2025

marketwatch TTE – Total Energies SE yahoo finance google finance

stock history TTE – Total Energies SE invest stock market

stock prices TTE premarket after hours

ticker TTE fair value insiders trading

CSTM – Constellium SE

CSTM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

3.59

Margin Of Safety %

Put/Call OI Ratio

0.49

EPS Next Q Diff

-0.25

EPS Last/This Y

1.46

EPS This/Next Y

-0.82

Price

22.36

Target Price

33.5

Analyst Recom

1.33

Performance Q

-25.3

Upside

138.5%

Beta

1.63

Ticker: CSTM

23 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-14	CSTM	25.36	0.42	0.22	31280
2026-10-15	CSTM	25.46	0.42	0.04	31269
2026-10-16	CSTM	25.45	0.40	0.36	32202
2026-10-19	CSTM	25.55	0.42	0.02	30036
2026-10-20	CSTM	25.76	0.40	0.23	31244
2026-10-21	CSTM	25.59	0.40	0.30	31349
2026-10-22	CSTM	23.96	0.40	1.39	31524
2026-10-23	CSTM	23.19	0.40	1.02	31603
2026-10-26	CSTM	23.4	0.40	0.70	31639
2026-10-27	CSTM	24.55	0.41	9.12	31673
2026-10-28	CSTM	24.46	0.46	0.62	32820
2026-10-29	CSTM	24	0.46	0.46	32811
2026-10-30	CSTM	23.1	0.46	0.81	32790
2026-11-02	CSTM	22.98	0.46	1.41	32766
2026-11-03	CSTM	23.02	0.46	1.54	32750
2026-11-04	CSTM	22.72	0.46	6.28	32996
2026-11-05	CSTM	21	0.49	0.97	33712
2026-11-06	CSTM	21.82	0.48	0.01	33427
2026-11-09	CSTM	22.77	0.50	0.08	32489
2026-11-10	CSTM	22.46	0.50	1.11	32683
2026-11-11	CSTM	23.02	0.50	3.44	32751
2026-11-12	CSTM	22.6	0.50	0.04	32796
2026-11-13	CSTM	22.35	0.49	0.09	33364
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-14	CSTM	25.35	58.0	-	3.53
2026-10-15	CSTM	25.48	54.1	-	3.53
2026-10-16	CSTM	25.48	54.1	-	3.71
2026-10-19	CSTM	25.55	58.0	-	3.53
2026-10-20	CSTM	25.55	58.0	-	3.53
2026-10-21	CSTM	25.75	58.0	-	3.53
2026-10-22	CSTM	23.97	58.0	-	3.53
2026-10-23	CSTM	23.19	58.0	-	3.53
2026-10-26	CSTM	23.40	58.0	-	3.53
2026-10-27	CSTM	24.53	58.0	-	3.53
2026-10-28	CSTM	24.44	58.0	-	3.53
2026-10-29	CSTM	24.00	58.0	-	3.53
2026-10-30	CSTM	23.11	-15.3	-	3.53
2026-11-02	CSTM	22.97	-15.3	-	3.53
2026-11-03	CSTM	23.02	-33.6	-	3.41
2026-11-04	CSTM	22.72	-33.6	-	3.41
2026-11-05	CSTM	21.00	-33.6	-	3.41
2026-11-06	CSTM	21.81	-33.6	-	3.41
2026-11-09	CSTM	22.76	-33.6	-	3.41
2026-11-10	CSTM	22.47	-33.6	-	3.41
2026-11-11	CSTM	23.02	-33.6	-	3.41
2026-11-12	CSTM	22.59	-33.6	-	3.41
2026-11-13	CSTM	22.36	-33.6	-	3.41
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-14	CSTM	-1.54	-0.15	5.07
2026-10-15	CSTM	-1.54	-0.15	5.07
2026-10-16	CSTM	-1.54	-0.15	5.07
2026-10-19	CSTM	-1.54	0.22	5.07
2026-10-20	CSTM	-1.54	0.22	5.07
2026-10-21	CSTM	-1.54	0.22	5.07
2026-10-22	CSTM	-1.54	0.22	5.07
2026-10-23	CSTM	-1.54	0.22	5.07
2026-10-26	CSTM	-1.54	0.20	5.07
2026-10-27	CSTM	-1.54	0.20	4.76
2026-10-28	CSTM	-1.54	0.20	4.76
2026-10-29	CSTM	-1.54	0.20	4.76
2026-10-30	CSTM	-1.54	0.20	4.76
2026-11-02	CSTM	-1.56	0.04	4.79
2026-11-03	CSTM	-1.54	0.04	4.79
2026-11-05	CSTM	-1.11	0.04	4.79
2026-11-06	CSTM	-0.70	0.04	4.79
2026-11-09	CSTM	-0.41	-0.76	4.79
2026-11-10	CSTM	-0.41	-0.76	4.79
2026-11-11	CSTM	-0.41	-0.76	3.59
2026-11-12	CSTM	-0.41	-0.76	3.59
2026-11-13	CSTM	-0.15	-0.76	3.59
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.84

Avg. EPS Est. Current Quarter

0.45

Avg. EPS Est. Next Quarter

0.59

Insider Transactions

-0.15

Institutional Transactions

-0.76

Beta

1.63

Average Sales Estimate Current Quarter

2191

Average Sales Estimate Next Quarter

2235

Fair Value

26.19

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

39.6

Max Drawdown 5-Year %

-66.3

Target Price

33.5

P/E

5.45

Forward P/E

8.29

PEG

0.27

P/S

0.3

P/B

2.25

P/Free Cash Flow

9.4

EPS

4.1

Average EPS Est. Cur. Y

3.41

EPS Next Y. (Est.)

2.6

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

5.71

Relative Volume

0.64

Return on Equity vs Sector %

25.8

Return on Equity vs Industry %

24.7

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.25

EBIT Estimation

◆ CSTM Basic Materials

$22.35

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

11/25

Volume

6/15

Valuation

18/20

TP/AR

2/10

Options

7/10

RSI

40.2

Range 1M

26.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

21/30

Estimates

4/20

Inst/Vol

1/15

Options

9/10

EPS Yr

227.1%

EPS NY

-33.3%

52W%

34.2%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +40.7% upside

Quality

16/30

Valuation

20/30

Growth

14/25

Stability

3/10

LT Trend

3/5

Upside

+40.7%

Quality

MoS

17%

CSTM — P/E HistoricalAluminum

Constellium SE

Sector: Basic Materials

Industry: Aluminum

Employees: 11500

Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea, Japan and China. The company was incorporated in 2010 and is headquartered in Paris, France.

CSTM

Latest News

—

Caricamento notizie per CSTM…

stock quote shares CSTM – Constellium SE Stock Price stock today

news today CSTM – Constellium SE stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTM – Constellium SE yahoo finance google finance

stock history CSTM – Constellium SE invest stock market

stock prices CSTM premarket after hours

ticker CSTM fair value insiders trading

ABVX – Abivax ADR

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: ABVX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

SNY – Sanofi

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SNY

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y